Jhw. Van Der Heijden et al., Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease, CLIN EXP IM, 118(2), 1999, pp. 205-212
Graves' disease (GD) is characterized by the presence of autoantibodies aga
inst the TSH-receptor (TSH-R) which are pathogenic and, upon binding to the
receptor, trigger intracellular signal transduction. The autoantibodies ar
e oligoclonal and as they are responsible for disease activity, their chara
cterization would lead to a better understanding of the development of GD.
Attempts to isolate anti-TSH-R antibodies from patients have proved to be d
ifficult due to the exceedingly low serum levels due to rarity of these B c
ells, together with difficulties in obtaining purified TSH-R capable of int
eracting with patients autoantibodies. We employed phage antibody display t
echnology and performed selection with a previously characterized semisynth
etic antibody library on the purified extracellular ectodomain of the TSH-R
. We report the isolation of six different anti-TSH-R monoclonal phage anti
bodies (moPhabs) from this library. All the moPhabs recognized TSH-R and it
s recombinant fragments by Western blotting, but failed to recognize the na
tive TSH-R by flow cytometry. Consequently, the moPhabs did not lead to TSH
-R activation. As these were the first moPhabs to TSH-R, they were analysed
in terms of nucleotide and amino acid sequence and epitope specificity on
the receptor. The moPhabs used immunoglobulin VH1 and VH3 germ line genes,
all associated with V lambda 3 genes. Interestingly, the CDR3 regions of al
l moPhabs were remarkably similar, though not identical. In light of the co
mmon CDR3 usage, the epitopes recognized on TSH-R appeared to be restricted
to amino acids residues 405-411 and 357-364. In summary, our results show
that semisynthetic libraries may be limited in isolating human monoclonal a
ntibodies that resemble pathogenic antithyrotropin receptor autoantibodies
present in patients with GD. It is likely that until preparations of purifi
ed TSH-R that can be recognized by patients autoantibodies become available
, similar to the recently described glycosylphosphatidylinositol (GPI) anch
ored TSH-R ectodomain, monoclonal antibodies from phage antibody display to
TSH-R will be limited for isolating the rare, pathogenic antibodies of GD.